<record>
  <datafield tag="024" ind1="7" ind2=" ">
    <subfield code="a">10.1016/j.apradiso.2016.12.058</subfield>
    <subfield code="2">DOI</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Das, Tapas</subfield>
    <subfield code="v">Radiopharmaceuticals Chemistry Section, Radiochemistry and Isotope Group, Bhabha Atomic Research Centre, Trombay, Mumbai, 400085, India</subfield>
    <subfield code="v">Homi Bhabha National Institute, Anushaktinagar, Mumbai, 400094, India</subfield>
    <subfield code="m">tdas@barc.gov.in</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Radiochemical studies, pre-clinical investigation and preliminary clinical evaluation of 170 Tm-EDTMP prepared using in-house freeze-dried EDTMP kit</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2017-04</subfield>
    <subfield code="t">published</subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
    <subfield code="a">7</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">The objective of the present work is to formulate 170 Tm-EDTMP using an in-house freeze-dried EDTMP kit and evaluate its potential as a bone pain palliation agent. Patient dose of 170 Tm-EDTMP was prepared with high radiochemical purity using the lyophilized kit at room temperature within 15 min. Pre-clinical evaluation in normal Wistar rats revealed selective skeletal accumulation with extended retention. Preliminary clinical investigation in 8 patients with disseminated skeletal metastases exhibited selective uptake in the bone and retention therein for a long duration.</subfield>
    <subfield code="9">Elsevier</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="f">Elsevier Ltd</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">Metastatic bone pain palliation</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">170 Tm</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">170 Tm-EDTMP</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">Freeze-dried EDTMP kit</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">Pharmacokinetics</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">170Tm</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">170Tm-EDTMP</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Shinto, Ajit</subfield>
    <subfield code="v">Department of Nuclear Medicine &amp; PET, Kovai Medical Centre and Hospital, Coimbatore, Tamil Nadu, 641014, India</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Kamaleshwaran, Koramadai K.</subfield>
    <subfield code="v">Department of Nuclear Medicine &amp; PET, Kovai Medical Centre and Hospital, Coimbatore, Tamil Nadu, 641014, India</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Sarma, Haladhar D.</subfield>
    <subfield code="v">Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Trombay, Mumbai, 400085, India</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Mohammed, Sahiralam Khan</subfield>
    <subfield code="v">Isotope Production and Applications Division, Bhabha Atomic Research Centre, Trombay, Mumbai, 400085, India</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Mitra, Arpit</subfield>
    <subfield code="v">Radiation Medicine Cnetre, Bhabha Atomic Research Centre, Mumbai, 400012, India</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Lad, Sangita</subfield>
    <subfield code="v">Radiation Medicine Cnetre, Bhabha Atomic Research Centre, Mumbai, 400012, India</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Rajan, M.G.R.</subfield>
    <subfield code="v">Homi Bhabha National Institute, Anushaktinagar, Mumbai, 400094, India</subfield>
    <subfield code="v">Radiation Medicine Cnetre, Bhabha Atomic Research Centre, Mumbai, 400012, India</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Banerjee, Sharmila</subfield>
    <subfield code="v">Radiopharmaceuticals Chemistry Section, Radiochemistry and Isotope Group, Bhabha Atomic Research Centre, Trombay, Mumbai, 400085, India</subfield>
    <subfield code="v">Homi Bhabha National Institute, Anushaktinagar, Mumbai, 400094, India</subfield>
  </datafield>
  <datafield tag="773" ind1=" " ind2=" ">
    <subfield code="p">Appl.Radiat.Isot.</subfield>
    <subfield code="c">7-13</subfield>
    <subfield code="v">122</subfield>
    <subfield code="y">2017</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">HEP</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">Citeable</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">Published</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Abi-Ghanem, A.S.</subfield>
    <subfield code="h">McGrath, M.A.</subfield>
    <subfield code="h">Jacene, H.A.</subfield>
    <subfield code="t">Radionuclide therapy for osseous metastases in prostate cancer</subfield>
    <subfield code="v">45</subfield>
    <subfield code="y">2015</subfield>
    <subfield code="o">Abi-Ghanem et al, 2015</subfield>
    <subfield code="s">Semin.Nucl.Med.,45,66</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Agarwal, K.K.</subfield>
    <subfield code="h">Singla, S.</subfield>
    <subfield code="h">Arora, G.</subfield>
    <subfield code="h">Bal, C.S.</subfield>
    <subfield code="t">177 Lu-EDTMP for palliation of pain from bone metastases in patients with prostate and breast cancer: a phase II study</subfield>
    <subfield code="v">42</subfield>
    <subfield code="y">2015</subfield>
    <subfield code="o">Agarwal et al, 2015</subfield>
    <subfield code="s">Eur.J.Nucl.Med.Mol.Imaging,42,79</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Atkins, H.L.</subfield>
    <subfield code="h">Mausner, L.F.</subfield>
    <subfield code="h">Srivastava, S.C.</subfield>
    <subfield code="h">Meinken, G.E.</subfield>
    <subfield code="h">Cabahug, C.J.</subfield>
    <subfield code="h">D'Alessandro, T.</subfield>
    <subfield code="t">Tin-117m(4+)-DTPA for palliation of pain from osseous metastases: a pilot study</subfield>
    <subfield code="v">36</subfield>
    <subfield code="y">1995</subfield>
    <subfield code="o">Atkins et al, 1995</subfield>
    <subfield code="s">J.Nucl.Med.,36,725</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Bahrami-Samani, A.</subfield>
    <subfield code="h">Bagheri, R.</subfield>
    <subfield code="h">Jalilian, A.R.</subfield>
    <subfield code="h">Shirvani-Arani, S.</subfield>
    <subfield code="h">Ghannadi-Maragheh, M.</subfield>
    <subfield code="h">Shamsaee, M.</subfield>
    <subfield code="t">Production, quality control and pharmacokinetic studies of 166 Ho-EDTMP for therapeutic applications</subfield>
    <subfield code="v">78</subfield>
    <subfield code="y">2010</subfield>
    <subfield code="o">Bahrami-Samani et al, 2010</subfield>
    <subfield code="s">Sci.Pharm.,78,423</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Bishayee, A.</subfield>
    <subfield code="h">Rao, D.V.</subfield>
    <subfield code="h">Srivastava, S.C.</subfield>
    <subfield code="h">Bouchet, L.G.</subfield>
    <subfield code="h">Bloch, W.E.</subfield>
    <subfield code="h">Howell, R.W.</subfield>
    <subfield code="t">Marrow-sparing effects of 117m Sn(4+) diethylenetriaminepentaacetic acid for radionuclidic therapy of bone cancer</subfield>
    <subfield code="v">41</subfield>
    <subfield code="y">2000</subfield>
    <subfield code="o">Bishayee et al, 2000</subfield>
    <subfield code="s">J.Nucl.Med.,41,2043</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Bos, S.D.</subfield>
    <subfield code="t">An overview of current clinical experience with Strontium-89 (MetastronÂ®)</subfield>
    <subfield code="v">25</subfield>
    <subfield code="y">1994</subfield>
    <subfield code="o">Bos, 1994</subfield>
    <subfield code="s">Prostate,25,23</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Bouchet, L.G.</subfield>
    <subfield code="h">Bolch, W.E.</subfield>
    <subfield code="h">Goddu, S.M.</subfield>
    <subfield code="h">Howell, R.W.</subfield>
    <subfield code="h">Rao, D.V.</subfield>
    <subfield code="t">Considerations in the selection of radiopharmaceuticals for palliation of bone pain from metastatic osseous lesions</subfield>
    <subfield code="v">41</subfield>
    <subfield code="y">2000</subfield>
    <subfield code="o">Bouchet et al, 2000</subfield>
    <subfield code="s">J.Nucl.Med.,41,682</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Carrasquillo, J.A.</subfield>
    <subfield code="h">O'Donoghue, J.A.</subfield>
    <subfield code="h">Pandit-Taskar, N.</subfield>
    <subfield code="h">Humm, J.L.</subfield>
    <subfield code="h">Rathkopf, D.E.</subfield>
    <subfield code="h">Slovin, S.F.</subfield>
    <subfield code="h">Williamson, M.J.</subfield>
    <subfield code="h">Lacuna, K.</subfield>
    <subfield code="h">Aksnes, A.K.</subfield>
    <subfield code="h">Larson, S.M.</subfield>
    <subfield code="h">Scher, H.I.</subfield>
    <subfield code="h">Morris, M.J.</subfield>
    <subfield code="t">Phase I pharmacokinetic and biodistribution study with escalating doses of 223 Ra-dichloride in men with castration-resistant metastatic prostate cancer</subfield>
    <subfield code="v">40</subfield>
    <subfield code="y">2013</subfield>
    <subfield code="o">Carrasquillo et al, 2013</subfield>
    <subfield code="s">Eur.J.Nucl.Med.Mol.Imaging,40,1384</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Chakraborty, S.</subfield>
    <subfield code="h">Das, T.</subfield>
    <subfield code="h">Banerjee, S.</subfield>
    <subfield code="h">Balogh, L.</subfield>
    <subfield code="h">Chaudhari, P.R.</subfield>
    <subfield code="h">Sarma, H.D.</subfield>
    <subfield code="h">PolyÃ¡k, A.</subfield>
    <subfield code="h">MÃ¡thÃ©, D.</subfield>
    <subfield code="h">Venkatesh, M.</subfield>
    <subfield code="h">Janoki, G.</subfield>
    <subfield code="h">Pillai, M.R.A.</subfield>
    <subfield code="t">177 Lu-EDTMP: a viable bone pain palliative in skeletal metastasis</subfield>
    <subfield code="v">23</subfield>
    <subfield code="y">2008</subfield>
    <subfield code="o">Chakraborty et al, 2008</subfield>
    <subfield code="s">Cancer Biother.Radiopharm.,23,202</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Das, T.</subfield>
    <subfield code="h">Pillai, M.R.A.</subfield>
    <subfield code="t">Options to meet the future global demand of radionuclides for radionuclide therapy</subfield>
    <subfield code="v">40</subfield>
    <subfield code="y">2013</subfield>
    <subfield code="o">Das and Pillai, 2013</subfield>
    <subfield code="s">Nucl.Med.Biol.,40,23</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Das, T.</subfield>
    <subfield code="h">Chakraborty, S.</subfield>
    <subfield code="h">Sarma, H.D.</subfield>
    <subfield code="h">Tandon, P.</subfield>
    <subfield code="h">Banerjee, S.</subfield>
    <subfield code="h">Venkatesh, M.</subfield>
    <subfield code="h">Pillai, M.R.A.</subfield>
    <subfield code="t">170 Tm-EDTMP: a potential cost-effective alternative to 89 SrCl 2 for bone pain palliation</subfield>
    <subfield code="v">36</subfield>
    <subfield code="y">2009</subfield>
    <subfield code="o">Das et al, 2009</subfield>
    <subfield code="s">Nucl.Med.Biol.,36,561</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Das, T.</subfield>
    <subfield code="h">Sarma, H.D.</subfield>
    <subfield code="h">Shinto, A.</subfield>
    <subfield code="h">Kamaleshwaran, K.K.</subfield>
    <subfield code="h">Banerjee, S.</subfield>
    <subfield code="t">Formulation, pre-clinical evaluation and preliminary clinical investigation of an in-house freeze-dried EDTMP kit suitable for the preparation of 177 Lu-EDTMP</subfield>
    <subfield code="v">29</subfield>
    <subfield code="y">2014</subfield>
    <subfield code="o">Das et al, 2014</subfield>
    <subfield code="s">Cancer Biother.Radiopharm.,29,412</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">DeNardo, G.L.</subfield>
    <subfield code="t">Bone Pain Palliation</subfield>
    <subfield code="v">13</subfield>
    <subfield code="y">1998</subfield>
    <subfield code="o">DeNardo, 1998</subfield>
    <subfield code="s">Cancer Biother.Radiopharm.,13,407</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Garrett, I.R.</subfield>
    <subfield code="t">Bone destruction in cancer</subfield>
    <subfield code="v">20</subfield>
    <subfield code="y">1993</subfield>
    <subfield code="o">Garrett, 1993</subfield>
    <subfield code="s">Semin.Oncol.,20,4</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Giammarile, F.</subfield>
    <subfield code="h">Mognetti, T.</subfield>
    <subfield code="h">Resche, I.</subfield>
    <subfield code="t">Bone pain palliation with strontium-89 in cancer patients with bone metastases</subfield>
    <subfield code="v">45</subfield>
    <subfield code="y">2010</subfield>
    <subfield code="o">Giammarile et al, 2010</subfield>
    <subfield code="s">Q.J.Nucl.Med.Mol.Imaging,45,78</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Greco, C.</subfield>
    <subfield code="h">Forte, L.</subfield>
    <subfield code="h">Erba, P.</subfield>
    <subfield code="h">Mariani, G.</subfield>
    <subfield code="t">Bone metastases, general and clinical issues</subfield>
    <subfield code="v">55</subfield>
    <subfield code="y">2011</subfield>
    <subfield code="o">Greco et al, 2011</subfield>
    <subfield code="s">Q.J.Nucl.Med.Mol.Imaging,55,337</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Lam, M.G.E.H.</subfield>
    <subfield code="h">de Klerk, J.M.H.</subfield>
    <subfield code="h">van Rijk, P.P.</subfield>
    <subfield code="t">186 Re-HEDP for metastatic bone pain in breast cancer patients</subfield>
    <subfield code="v">31</subfield>
    <subfield code="y">2004</subfield>
    <subfield code="o">Lam et al, 2004</subfield>
    <subfield code="s">Eur.J.Nucl.Med.Mol.Imaging,31,S162</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="a">10.1118/1.4897240</subfield>
    <subfield code="h">Liberal, F.D.C.G.</subfield>
    <subfield code="h">Tavares, A.A.S.</subfield>
    <subfield code="h">Tavares, J.M.R.S.</subfield>
    <subfield code="t">Comparative analysis of 11 different radioisotopes for palliative treatment of bone metastases by computational methods</subfield>
    <subfield code="y">2014</subfield>
    <subfield code="o">Liberal et al, 2014</subfield>
    <subfield code="s">Med.Phys.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Liepe, K.</subfield>
    <subfield code="h">Hliscs, R.</subfield>
    <subfield code="h">Kropp, J.</subfield>
    <subfield code="h">Runge, R.</subfield>
    <subfield code="h">Knapp, F.F. Jr</subfield>
    <subfield code="h">Franke, W.G.</subfield>
    <subfield code="t">Dosimetry of 188 Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases</subfield>
    <subfield code="v">44</subfield>
    <subfield code="y">2003</subfield>
    <subfield code="o">Liepe et al, 2003a</subfield>
    <subfield code="s">J.Nucl.Med.,44,953</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Liepe, K.</subfield>
    <subfield code="h">Kropp, J.</subfield>
    <subfield code="h">Runge, R.</subfield>
    <subfield code="h">Kotzerke, J.</subfield>
    <subfield code="t">Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases</subfield>
    <subfield code="v">89</subfield>
    <subfield code="y">2003</subfield>
    <subfield code="o">Liepe et al, 2003b</subfield>
    <subfield code="s">Br.J.Cancer,89,625</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Louw, W.K.A.</subfield>
    <subfield code="h">Dormehl, I.C.</subfield>
    <subfield code="h">Van Rensburg, A.J.</subfield>
    <subfield code="h">Hugo, N.</subfield>
    <subfield code="h">Alberts, A.S.</subfield>
    <subfield code="h">Forsyth, O.E.</subfield>
    <subfield code="h">Beverley, G.</subfield>
    <subfield code="h">Sweetlove, M.A.</subfield>
    <subfield code="h">Marais, J.</subfield>
    <subfield code="h">LÃ¶tter, M.G.</subfield>
    <subfield code="h">Van Aswegen, A.</subfield>
    <subfield code="t">Evaluation of samarium-153 and holmium-166-EDTMP in the normal baboon model</subfield>
    <subfield code="v">23</subfield>
    <subfield code="y">1996</subfield>
    <subfield code="o">Louw et al, 1996</subfield>
    <subfield code="s">Nucl.Med.Biol.,23,935</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Maini, C.L.</subfield>
    <subfield code="h">Sciuto, R.</subfield>
    <subfield code="h">Romano, L.</subfield>
    <subfield code="h">Bergomi, S.</subfield>
    <subfield code="t">Radionuclide therapy with bone seeking radionuclides in palliation of painful bone metastases</subfield>
    <subfield code="v">22</subfield>
    <subfield code="y">2003</subfield>
    <subfield code="o">Maini et al, 2003</subfield>
    <subfield code="s">J.Exp.Clin.Cancer Res.,22,71</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Maini, C.L.</subfield>
    <subfield code="h">Bergomi, S.</subfield>
    <subfield code="h">Romano, L.</subfield>
    <subfield code="h">Sciuto, R.</subfield>
    <subfield code="t">153 Sm-EDTMP for bone pain palliation in metastases</subfield>
    <subfield code="v">31</subfield>
    <subfield code="y">2004</subfield>
    <subfield code="o">Maini et al, 2004</subfield>
    <subfield code="s">Eur.J.Nucl.Med.Mol.Imaging,31,S171</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Mathew, B.</subfield>
    <subfield code="h">Chakraborty, S.</subfield>
    <subfield code="h">Das, T.</subfield>
    <subfield code="h">Sarma, H.D.</subfield>
    <subfield code="h">Banerjee, S.</subfield>
    <subfield code="h">Samuel, G.</subfield>
    <subfield code="h">Venkatesh, M.</subfield>
    <subfield code="h">Pillai, M.R.A.</subfield>
    <subfield code="t">175 Yb labeled polyaminophosphonates as potential agents for bone pain palliation</subfield>
    <subfield code="v">60</subfield>
    <subfield code="y">2004</subfield>
    <subfield code="o">Mathew et al, 2004</subfield>
    <subfield code="s">Appl.Radiat.Isot.,60,635</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Mertens, W.C.</subfield>
    <subfield code="h">Filipczak, L.A.</subfield>
    <subfield code="h">Ben-Josef, E.</subfield>
    <subfield code="h">Davis, L.P.</subfield>
    <subfield code="h">Porter, A.P.</subfield>
    <subfield code="t">Systemic bone-seeking radionuclides for palliation of painful osseous metastases: current concepts</subfield>
    <subfield code="v">48</subfield>
    <subfield code="y">1998</subfield>
    <subfield code="o">Mertens et al, 1998</subfield>
    <subfield code="s">CA: Cancer J.Clin.,48,361</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Michel, D.</subfield>
    <subfield code="h">Wissing, M.D.</subfield>
    <subfield code="h">van Leeuwen, F.W.B.</subfield>
    <subfield code="h">van der Pluijm, G.</subfield>
    <subfield code="h">Gelderblom, H.</subfield>
    <subfield code="t">Radium-223 Chloride: extending life in prostate cancer patients by treating bone metastases</subfield>
    <subfield code="v">19</subfield>
    <subfield code="y">2013</subfield>
    <subfield code="o">Michel et al, 2013</subfield>
    <subfield code="s">Clin.Cancer Res.,19,5822</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Minutoli, F.</subfield>
    <subfield code="h">Herberg, A.</subfield>
    <subfield code="h">Spadaro, P.</subfield>
    <subfield code="h">Restifo Pecorella, G.</subfield>
    <subfield code="h">Baldari, S.</subfield>
    <subfield code="h">AricÃ², D.</subfield>
    <subfield code="h">Altavilla, G.</subfield>
    <subfield code="h">Baldari, S.</subfield>
    <subfield code="t">[ 186 Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast</subfield>
    <subfield code="v">50</subfield>
    <subfield code="y">2006</subfield>
    <subfield code="o">Minutoli et al, 2006</subfield>
    <subfield code="s">Q.J.Nucl.Med.Mol.Imaging,50,355</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Nilsson, S.</subfield>
    <subfield code="h">Strang, P.</subfield>
    <subfield code="h">Aksnes, A.K.</subfield>
    <subfield code="h">Franzen, L.</subfield>
    <subfield code="h">Olivier, P.</subfield>
    <subfield code="h">Pecking, A.</subfield>
    <subfield code="h">Staffurth, J.</subfield>
    <subfield code="h">Vasanthan, S.</subfield>
    <subfield code="h">Anderson, C.</subfield>
    <subfield code="h">Bruland, Ã.S.</subfield>
    <subfield code="t">A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer</subfield>
    <subfield code="v">48</subfield>
    <subfield code="y">2012</subfield>
    <subfield code="o">Nilsson et al, 2012</subfield>
    <subfield code="s">Eur.J.Cancer,48,678</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Paes, F.M.</subfield>
    <subfield code="h">Serafini, A.N.</subfield>
    <subfield code="t">Systemic metabolic radiopharmaceutical therapy in the treatment of metastatic bone pain</subfield>
    <subfield code="v">40</subfield>
    <subfield code="y">2010</subfield>
    <subfield code="o">Paes and Serafini, 2010</subfield>
    <subfield code="s">Semin.Nucl.Med.,40,89</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Palma, E.</subfield>
    <subfield code="h">Correia, J.D.G.</subfield>
    <subfield code="h">Campello, M.P.C.</subfield>
    <subfield code="h">Santos, I.</subfield>
    <subfield code="t">Bisphosphonates as radionuclide carriers for imaging or systemic therapy</subfield>
    <subfield code="v">7</subfield>
    <subfield code="y">2011</subfield>
    <subfield code="o">Palma et al, 2011</subfield>
    <subfield code="s">Mol.Biosyst.,7,2950</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Pandit-Taskar, N.</subfield>
    <subfield code="h">Batraki, M.</subfield>
    <subfield code="h">Divgi, C.R.</subfield>
    <subfield code="t">Radiopharmaceutical therapy for palliation of bone pain from osseous metastases</subfield>
    <subfield code="v">45</subfield>
    <subfield code="y">2004</subfield>
    <subfield code="o">Pandit-Taskar et al, 2004</subfield>
    <subfield code="s">J.Nucl.Med.,45,1358</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">RÃ¶sch, F.</subfield>
    <subfield code="h">Herzog, H.</subfield>
    <subfield code="h">Plag, C.</subfield>
    <subfield code="h">Neumaier, B.</subfield>
    <subfield code="h">Braun, U.</subfield>
    <subfield code="h">MÃ¼ller-GÃ¤rtner, H.W.</subfield>
    <subfield code="h">StÃ¶cklin, G.</subfield>
    <subfield code="t">Radiation doses of yttrium-90 citrate and yttrium-90 EDTMP as determined via analogous yttrium-86 complexes and positron emission tomography</subfield>
    <subfield code="v">23</subfield>
    <subfield code="y">1996</subfield>
    <subfield code="o">RÃ¶sch et al, 1996</subfield>
    <subfield code="s">Eur.J.Nucl.Med.,23,958</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Shinto, A.S.</subfield>
    <subfield code="h">Shibu, D.</subfield>
    <subfield code="h">Kamaleshwaran, K.K.</subfield>
    <subfield code="h">Das, T.</subfield>
    <subfield code="h">Chakraborty, S.</subfield>
    <subfield code="h">Banerjee, S.</subfield>
    <subfield code="h">Thirumalaisamy, P.</subfield>
    <subfield code="h">Das, P.</subfield>
    <subfield code="h">Veersekar, G.</subfield>
    <subfield code="t">177 Lu-EDTMP for treatment of bone pain in patients with disseminated skeletal metastases</subfield>
    <subfield code="v">42</subfield>
    <subfield code="y">2014</subfield>
    <subfield code="o">Shinto et al, 2014</subfield>
    <subfield code="s">J.Nucl.Med.Technol.,42,55</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Shirvani-Arani, S.</subfield>
    <subfield code="h">Bahrami-Samani, A.</subfield>
    <subfield code="h">Meftahi, M.</subfield>
    <subfield code="h">Jalilian, A.R.</subfield>
    <subfield code="h">Ghannadi-Maragheh, M.</subfield>
    <subfield code="t">Production, quality control and biodistribution studies of thulium-170-labeled ethylenediamine (tetramethylene phosphonic acid)</subfield>
    <subfield code="v">101</subfield>
    <subfield code="y">2013</subfield>
    <subfield code="o">Shirvani-Arani et al, 2013</subfield>
    <subfield code="s">Radiochim.Acta,101,37</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Sohaib, M.</subfield>
    <subfield code="h">Ahmad, M.</subfield>
    <subfield code="h">Jehangir, M.</subfield>
    <subfield code="h">Perveen, A.</subfield>
    <subfield code="t">Ethylene diamine tetramethylene phosphonic acid labeled with various Î² - -emitting radiometals: labeling optimization and animal biodistribution</subfield>
    <subfield code="v">26</subfield>
    <subfield code="y">2011</subfield>
    <subfield code="o">Sohaib et al, 2011</subfield>
    <subfield code="s">Cancer Biother.Radiopharm.,26,159</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Thapa, P.</subfield>
    <subfield code="h">Nikam, D.</subfield>
    <subfield code="h">Das, T.</subfield>
    <subfield code="h">Sonawane, G.</subfield>
    <subfield code="h">Agarwal, J.P.</subfield>
    <subfield code="h">Basu, S.</subfield>
    <subfield code="t">Clinical efficacy and safety comparison of 177 Lu-EDTMP with 153 Sm-EDTMP on an equidose basis in patients with painful skeletal metastases</subfield>
    <subfield code="v">56</subfield>
    <subfield code="y">2015</subfield>
    <subfield code="o">Thapa et al, 2015</subfield>
    <subfield code="s">J.Nucl.Med.,56,1513</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Vats, K.</subfield>
    <subfield code="h">Das, T.</subfield>
    <subfield code="h">Sarma, H.D.</subfield>
    <subfield code="h">Banerjee, S.</subfield>
    <subfield code="h">Pillai, M.R.A.</subfield>
    <subfield code="t">Radiolabeling, stability studies, and pharmacokinetic evaluation of Thulium-170-labeled acyclic and cyclic polyaminopolyphosphonic acids</subfield>
    <subfield code="v">28</subfield>
    <subfield code="y">2013</subfield>
    <subfield code="o">Vats et al, 2013</subfield>
    <subfield code="s">Cancer Biother.Radiopharm.,28,737</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Vimalnath, K.V.</subfield>
    <subfield code="h">Shetty, P.</subfield>
    <subfield code="h">Chakraborty, S.</subfield>
    <subfield code="h">Das, T.</subfield>
    <subfield code="h">Chirayil, V.</subfield>
    <subfield code="h">Sarma, H.D.</subfield>
    <subfield code="h">Jagadeesan, K.C.</subfield>
    <subfield code="h">Joshi, P.V.</subfield>
    <subfield code="t">Practicality of production of 32 P by direct neutron activation for its utilization in bone pain palliation as Na 3 [ 32 P]PO 4</subfield>
    <subfield code="v">28</subfield>
    <subfield code="y">2013</subfield>
    <subfield code="o">Vimalnath et al, 2013</subfield>
    <subfield code="s">Cancer Biother.Radiopharm.,28,423</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Volkert, W.A.</subfield>
    <subfield code="h">Hoffman, T.J.</subfield>
    <subfield code="t">Therapeutic radiopharmaceuticals</subfield>
    <subfield code="v">99</subfield>
    <subfield code="y">1999</subfield>
    <subfield code="o">Volkert and Hoffman, 1999</subfield>
    <subfield code="s">Chem.Rev.,99,2269</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Yuan, J.</subfield>
    <subfield code="h">Liu, C.</subfield>
    <subfield code="h">Liu, X.</subfield>
    <subfield code="h">Wang, Y.</subfield>
    <subfield code="h">Kuai, D.</subfield>
    <subfield code="h">Zhang, G.</subfield>
    <subfield code="h">Zaknun, J.J.</subfield>
    <subfield code="t">Efficacy and safety of 177 Lu-EDTMP in bone metastatic pain palliation in breast cancer and hormone refractory prostate cancer: a phase II study</subfield>
    <subfield code="v">38</subfield>
    <subfield code="y">2013</subfield>
    <subfield code="o">Yuan et al, 2013</subfield>
    <subfield code="s">Clin.Nucl.Med.,38,88</subfield>
  </datafield>
  <datafield tag="FFT" ind1=" " ind2=" ">
    <subfield code="a">/afs/cern.ch/project/inspire/uploads/elsevier/consyn/consyn-files/0969-8043/S0969804317X0002X/S0969804316302780/S0969804316302780.xml</subfield>
    <subfield code="t">Elsevier</subfield>
    <subfield code="o">HIDDEN</subfield>
  </datafield>
</record>